DUBLIN--(BUSINESS WIRE)--The "Global Autoimmune Disease Treatment Market - By Disease Type, Diagonostics, Products, Region - Market Size, Demand Forecasts, Industry Trends and Updates (2016-2022)" report has been added to Research and Markets' offering.
The global autoimmune diseases treatment market is estimated to grow at a CAGR of 3.80% for the forecasted period, and its market value is expected to reach $45.54 billion by 2022 from $36.41 billion in 2016.
The dominance of North America and Europe in the autoimmune disease market can be attributed to factors like prevalence of autoimmune diseases, increasing investments in R&D and higher disposable income in these regions. Factors such as improving health infrastructure, increasing awareness among people about heath care and increasing aging populations are going to fuel the rapid growth of autoimmune disease treatment market in Asia-Pacific region in the next five years.
Availability of various biosimilar drugs, Government initiatives and support to restrict autoimmune diseases are also major factors contributing for the growth of this market. Lack of standardized treatment for these diseases, Poorly trained physicians, low medical insurance coverage and low levels of awareness among public about these diseases are some of the challenges for this industry.
Companies Mentioned
- Abbott Laboratories
- Active Biotech
- Eli Lilly
- Bristol-Myers Squibb
- AstraZeneca plc
- Pfizer
- Biogen Idec
- Lupin Limited
- GlaxoSmithKline
- Amgen
- 4SC AG
- F. Hoffmann-La Roche Ltd.
- AutoImmune Inc
- Johnson & Johnson
- Bayer
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Market Overview
4. Market Dynamics
5. Global Autoimmune Disease Treatment Market Segmentation, Forecasts and Trends - By Revenue
6. By Disease type
7. By Diagonostics
8. By Products
9. By Region
10. Vendor Market Share Analysis
11. Company Profiles
12. Industry Structure
13. Global Autoimmune Disease Treatment market - Road Ahead
For more information about this report visit https://www.researchandmarkets.com/research/gw8kpm/global_autoimmune
